Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

Therapeutic applications of herbal/synthetic/bio-drug in oral cancer: An update

(2021) Therapeutic applications of herbal/synthetic/bio-drug in oral cancer: An update. European Journal of Pharmacology. p. 22. ISSN 0014-2999

[img] Text
Therapeutic applications of herbalsyntheticbio-drug in oral cancer An update.pdf

Download (7MB)

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Oral cancer, as one of the most prevalent and invasive cancers that invade local tissue, can cause metastasis, and have high mortality. In 2018, around 355,000 worldwide oral cancers occurred and resulted in 177,000 deaths. Estimates for the year 2020 include about 53,260 new cases added to previous year's cases, and the estimated death toll from this cancer in 2020 is about 10,750 deaths more than previous years. Despite recent advances in cancer diagnosis and treatment, unfortunately, 50 of people with cancer cannot be cured. Of course, it should be remembered that the type of treatment used greatly influences patient recovery. There are not many choices when it comes to treating oral cancer. Research efforts focusing on the discovery and evolution of innovative therapeutic approaches for oral cancer are essential. Such traditional methods of treating this type of cancer like surgery and chemotherapy, have evolved dramatically during the past thirty to forty years, but they continue to cause panic among patients due to their side effects. Therefore, it is necessary to study and use drugs that are less risky for the patient as well as to provide solutions to reduce chemotherapy-induced adverse events that prevent many therapeutic risks. As mentioned above, this study examines low-risk therapies such as herbal remedies, biological drugs, and synthetic drugs in the hope that they will be useful to physicians, researchers, and scientists around the world.

Item Type: Article
Keywords: Oral cancer Herbal drug Synthetic drug Bio-drug Treatment squamous-cell carcinoma epithelial-mesenchymal transition anti-egfr antibody phase-ii trial neck-cancer in-vitro concurrent chemoradiotherapy investigators choice molecular-mechanisms targeted delivery Pharmacology & Pharmacy
Page Range: p. 22
Journal or Publication Title: European Journal of Pharmacology
Journal Index: ISI
Volume: 890
Identification Number: https://doi.org/10.1016/j.ejphar.2020.173657
ISSN: 0014-2999
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/9840

Actions (login required)

View Item View Item